Literature DB >> 21471064

Autoimmunity in idiopathic pulmonary fibrosis: are circulating autoantibodies pathogenic or epiphenomena?

Carol A Feghali-Bostwick, David S Wilkes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21471064     DOI： 10.1164/rccm.201010-1727ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

Review 1.  Update in diffuse parenchymal lung disease 2011.

Authors:  Tracy R Luckhardt; Joachim Müller-Quernheim; Victor J Thannickal
Journal:  Am J Respir Crit Care Med       Date:  2012-07-01       Impact factor: 21.405

2.  Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.

Authors:  Venkataswarup Tiriveedhi; Baskaran Gautam; Nayan J Sarma; Medhat Askar; Marie Budev; Aviva Aloush; Ramsey Hachem; Elbert Trulock; Bryan Myers; Alexander G Patterson; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2013-08       Impact factor: 10.247

3.  A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

Authors:  Argyris Tzouvelekis; Vassilis Paspaliaris; George Koliakos; Paschalis Ntolios; Evangelos Bouros; Anastasia Oikonomou; Athanassios Zissimopoulos; Nikolaos Boussios; Brian Dardzinski; Dimitrios Gritzalis; Antonis Antoniadis; Marios Froudarakis; George Kolios; Demosthenes Bouros
Journal:  J Transl Med       Date:  2013-07-15       Impact factor: 5.531

4.  Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).

Authors:  Jonathan A Kropski; Bradley W Richmond; Christa F Gaskill; Robert F Foronjy; Susan M Majka
Journal:  Pulm Circ       Date:  2017-10-17       Impact factor: 3.017

5.  Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis.

Authors:  Katerina D Samara; Athina Trachalaki; Eliza Tsitoura; Anastasios V Koutsopoulos; Eleni D Lagoudaki; Ismini Lasithiotaki; George Margaritopoulos; Panagiotis Pantelidis; Eleni Bibaki; Nikolaos M Siafakas; Nikolaos Tzanakis; Athol U Wells; Katerina M Antoniou
Journal:  Respir Res       Date:  2017-12-29

6.  Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMJ Open       Date:  2019-05-29       Impact factor: 2.692

7.  Intrapulmonary Autoantibodies to HSP72 Are Associated with Improved Outcomes in IPF.

Authors:  Ross Mills; Abhinav Mathur; Lisa M Nicol; Jeremy J Walker; Alexander A Przybylski; Alison C Mackinnon; Sarah E M Howie; William A H Wallace; Ian Dransfield; Nik Hirani
Journal:  J Immunol Res       Date:  2019-04-11       Impact factor: 4.818

Review 8.  Molecular biomarkers in interstitial lung diseases.

Authors:  Angelo De Lauretis; Elisabetta A Renzoni
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

Review 9.  Modulation of bacterial pathogenesis by oppressive aging factors: insights into host-pneumococcal interaction strategies.

Authors:  Pooja Shivshankar
Journal:  ISRN Inflamm       Date:  2012-05-17

Review 10.  Natural Autoantibodies in Chronic Pulmonary Diseases.

Authors:  Kiyoharu Fukushima; Kazuyuki Tsujino; Shinji Futami; Hiroshi Kida
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.